Lisdexamfetamine, marketed as Vyvanse, is a controlled medication indicated for attention deficit hyperactivity disorder in kids and adults . In Canada, its distribution is overseen by Health Canada. This https://apo-lisdexamfetamine-in-579083.blog-center.com/61715386/this-medication-in-canada-a-detailed-guide